nodes	percent_of_prediction	percent_of_DWPC	metapath
Balsalazide—PTGS2—glaucoma	0.916	1	CbGaD
Balsalazide—PTGS1—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00404	0.052	CbGpPWpGaD
Balsalazide—PTGS2—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00321	0.0413	CbGpPWpGaD
Balsalazide—PTGS1—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.00276	0.0355	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—ATOH7—glaucoma	0.0024	0.0308	CbGpPWpGaD
Balsalazide—PTGS2—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.00219	0.0282	CbGpPWpGaD
Balsalazide—Bromfenac—PTGS2—glaucoma	0.00194	0.321	CrCbGaD
Balsalazide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00181	0.0233	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—TXN—glaucoma	0.00179	0.023	CbGpPWpGaD
Balsalazide—ALOX5—Arachidonic acid metabolism—CYP1B1—glaucoma	0.00174	0.0223	CbGpPWpGaD
Balsalazide—PPARG—Transcription factor regulation in adipogenesis—NR3C1—glaucoma	0.00153	0.0197	CbGpPWpGaD
Balsalazide—Olsalazine—PTGS2—glaucoma	0.00153	0.254	CrCbGaD
Balsalazide—Fenbufen—PTGS2—glaucoma	0.0015	0.249	CrCbGaD
Balsalazide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00146	0.0188	CbGpPWpGaD
Balsalazide—ALOX5—Eicosanoid Synthesis—PTGS2—glaucoma	0.00141	0.0181	CbGpPWpGaD
Balsalazide—PPARG—Signaling events mediated by HDAC Class I—HDAC9—glaucoma	0.00129	0.0166	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—ABCA1—glaucoma	0.0011	0.0142	CbGpPWpGaD
Balsalazide—Sulfasalazine—PTGS2—glaucoma	0.00106	0.176	CrCbGaD
Balsalazide—PTGS1—Overview of nanoparticle effects—FN1—glaucoma	0.00101	0.013	CbGpPWpGaD
Balsalazide—PPARG—Regulation of retinoblastoma protein—TGFB2—glaucoma	0.00101	0.013	CbGpPWpGaD
Balsalazide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—glaucoma	0.00101	0.013	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—CA1—glaucoma	0.000992	0.0128	CbGpPWpGaD
Balsalazide—PPARG—Nuclear Receptors—NR3C1—glaucoma	0.00099	0.0127	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—SOD1—glaucoma	0.000985	0.0127	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—OPN4—glaucoma	0.000954	0.0123	CbGpPWpGaD
Balsalazide—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—glaucoma	0.00094	0.0121	CbGpPWpGaD
Balsalazide—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000917	0.0118	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000895	0.0115	CbGpPWpGaD
Balsalazide—PPARG—Regulation of retinoblastoma protein—CCND2—glaucoma	0.000809	0.0104	CbGpPWpGaD
Balsalazide—PTGS2—Overview of nanoparticle effects—FN1—glaucoma	0.000804	0.0103	CbGpPWpGaD
Balsalazide—ALOX5—Arachidonic acid metabolism—PTGS2—glaucoma	0.000783	0.0101	CbGpPWpGaD
Balsalazide—PPARG—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.000783	0.0101	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—MTHFR—glaucoma	0.000781	0.01	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—TXN—glaucoma	0.000775	0.00997	CbGpPWpGaD
Balsalazide—PTGS1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000753	0.00969	CbGpPWpGaD
Balsalazide—PTGS1—Overview of nanoparticle effects—PTGS2—glaucoma	0.000736	0.00947	CbGpPWpGaD
Balsalazide—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000728	0.00936	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000639	0.00822	CbGpPWpGaD
Balsalazide—PPARG—Transcription factor regulation in adipogenesis—TNF—glaucoma	0.000631	0.00811	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—TXN—glaucoma	0.000616	0.00792	CbGpPWpGaD
Balsalazide—PTGS1—Eicosanoid Synthesis—PTGS2—glaucoma	0.000611	0.00785	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000604	0.00777	CbGpPWpGaD
Balsalazide—PTGS2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000598	0.00769	CbGpPWpGaD
Balsalazide—PPARG—PPARA activates gene expression—ABCA1—glaucoma	0.000572	0.00736	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—NARFL—glaucoma	0.000569	0.00731	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—CA5A—glaucoma	0.000569	0.00731	CbGpPWpGaD
Balsalazide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.00056	0.0072	CbGpPWpGaD
Balsalazide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.000552	0.0071	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—C1QB—glaucoma	0.000546	0.00703	CbGpPWpGaD
Balsalazide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000528	0.00679	CbGpPWpGaD
Balsalazide—PTGS1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000528	0.00679	CbGpPWpGaD
Balsalazide—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000511	0.00657	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—PTGS2—glaucoma	0.000498	0.00641	CbGpPWpGaD
Balsalazide—PTGS1—Overview of nanoparticle effects—TNF—glaucoma	0.000497	0.00639	CbGpPWpGaD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—glaucoma	0.000485	0.00623	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—ABCA1—glaucoma	0.000479	0.00616	CbGpPWpGaD
Balsalazide—PTGS2—S1P1 pathway—VEGFA—glaucoma	0.00046	0.00592	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—SOD1—glaucoma	0.000427	0.00549	CbGpPWpGaD
Balsalazide—PPARG—Regulation of retinoblastoma protein—CDKN2A—glaucoma	0.000415	0.00534	CbGpPWpGaD
Balsalazide—PTGS2—Overview of nanoparticle effects—TNF—glaucoma	0.000394	0.00507	CbGpPWpGaD
Balsalazide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.000386	0.00496	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—ABCA1—glaucoma	0.00038	0.00489	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000374	0.00481	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—NR3C1—glaucoma	0.00037	0.00476	CbGpPWpGaD
Balsalazide—PPARG—Regulation of retinoblastoma protein—CDKN1B—glaucoma	0.000367	0.00473	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—FAS—glaucoma	0.000359	0.00461	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—NARFL—glaucoma	0.000352	0.00453	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—CA5A—glaucoma	0.000352	0.00453	CbGpPWpGaD
Balsalazide—PTGS1—Biological oxidations—GSTT1—glaucoma	0.000352	0.00452	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—NGFR—glaucoma	0.00034	0.00437	CbGpPWpGaD
Balsalazide—PTGS1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000339	0.00437	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	0.000339	0.00436	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—MTHFR—glaucoma	0.000338	0.00435	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—TNF—glaucoma	0.000336	0.00432	CbGpPWpGaD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	0.000327	0.00421	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—NTRK1—glaucoma	0.000323	0.00416	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—NCK2—glaucoma	0.000317	0.00408	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	0.000316	0.00406	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—NGFR—glaucoma	0.00029	0.00372	CbGpPWpGaD
Balsalazide—PTGS1—Biological oxidations—CYP1B1—glaucoma	0.00028	0.00361	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—CA1—glaucoma	0.000278	0.00357	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000273	0.00351	CbGpPWpGaD
Balsalazide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.000271	0.00349	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—CTSA—glaucoma	0.000269	0.00346	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	0.000269	0.00346	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000262	0.00337	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—CA2—glaucoma	0.000254	0.00327	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—FAS—glaucoma	0.000253	0.00326	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—BDNF—glaucoma	0.000252	0.00324	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000251	0.00323	CbGpPWpGaD
Balsalazide—PPARG—Signaling events mediated by HDAC Class I—TNF—glaucoma	0.00025	0.00321	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000248	0.00319	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000248	0.00319	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—NARFL—glaucoma	0.000247	0.00317	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—CA5A—glaucoma	0.000247	0.00317	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—IL1A—glaucoma	0.000242	0.00311	CbGpPWpGaD
Balsalazide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—glaucoma	0.000232	0.00298	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000227	0.00292	CbGpPWpGaD
Balsalazide—PTGS1—Biological oxidations—GSTM1—glaucoma	0.000224	0.00288	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—PTGS2—glaucoma	0.000216	0.00278	CbGpPWpGaD
Balsalazide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.000213	0.00274	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000208	0.00267	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—PAX6—glaucoma	0.000205	0.00264	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—CA5A—glaucoma	0.000196	0.00252	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—NARFL—glaucoma	0.000196	0.00252	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000194	0.0025	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	0.00019	0.00245	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000187	0.00241	CbGpPWpGaD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	0.000182	0.00234	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—TXN—glaucoma	0.000179	0.0023	CbGpPWpGaD
Balsalazide—PTGS2—Disease—LRP12—glaucoma	0.000177	0.00228	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000172	0.00222	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—CA1—glaucoma	0.000172	0.00221	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000171	0.0022	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	0.000169	0.00217	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—CTSA—glaucoma	0.000166	0.00214	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000163	0.0021	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000162	0.00208	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—CA2—glaucoma	0.000157	0.00202	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—CDKN2B—glaucoma	0.000154	0.00198	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000154	0.00198	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000154	0.00198	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—TNF—glaucoma	0.000152	0.00196	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000147	0.00189	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	0.000146	0.00188	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—GSTT1—glaucoma	0.000139	0.00178	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—NR3C1—glaucoma	0.000135	0.00174	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	0.000128	0.00165	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000125	0.00161	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—CA1—glaucoma	0.00012	0.00155	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—MMP9—glaucoma	0.000119	0.00153	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—CTSA—glaucoma	0.000117	0.0015	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	0.000116	0.00149	CbGpPWpGaD
Balsalazide—PTGS2—Disease—FGFR1OP—glaucoma	0.000114	0.00147	CbGpPWpGaD
Balsalazide—PTGS2—Disease—HEYL—glaucoma	0.000114	0.00147	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000112	0.00144	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—TXN—glaucoma	0.000111	0.00142	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—ABCA1—glaucoma	0.000111	0.00142	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—CYP1B1—glaucoma	0.000111	0.00142	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—CA2—glaucoma	0.00011	0.00142	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000108	0.00138	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000108	0.00138	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000101	0.0013	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.0001	0.00129	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—CA1—glaucoma	9.56e-05	0.00123	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—TP53—glaucoma	9.47e-05	0.00122	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—CTSA—glaucoma	9.26e-05	0.00119	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—TNF—glaucoma	9.15e-05	0.00118	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—MMP2—glaucoma	9.05e-05	0.00116	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—GSTM1—glaucoma	8.84e-05	0.00114	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—CA2—glaucoma	8.74e-05	0.00112	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	8.73e-05	0.00112	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—GSTT1—glaucoma	8.59e-05	0.0011	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	8.54e-05	0.0011	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	8.54e-05	0.0011	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—TP53—glaucoma	8.07e-05	0.00104	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—MTHFR—glaucoma	7.81e-05	0.001	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—TXN—glaucoma	7.76e-05	0.000998	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—CDKN2B—glaucoma	7.42e-05	0.000954	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—APOE—glaucoma	7.27e-05	0.000935	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	7.26e-05	0.000934	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—CAV1—glaucoma	7.2e-05	0.000927	CbGpPWpGaD
Balsalazide—PTGS2—Disease—HDAC9—glaucoma	7.12e-05	0.000916	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.08e-05	0.000911	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.01e-05	0.000902	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.92e-05	0.000891	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—CYP1B1—glaucoma	6.84e-05	0.00088	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—ABCA1—glaucoma	6.84e-05	0.00088	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—MMP9—glaucoma	6.8e-05	0.000875	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—NR3C1—glaucoma	6.51e-05	0.000837	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	6.23e-05	0.000801	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—TXN—glaucoma	6.16e-05	0.000792	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—VEGFA—glaucoma	6.11e-05	0.000786	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—GSTT1—glaucoma	6.02e-05	0.000774	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.62e-05	0.000723	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.57e-05	0.000716	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	5.49e-05	0.000706	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—GSTM1—glaucoma	5.47e-05	0.000704	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—NOS3—glaucoma	5.45e-05	0.000701	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—TNF—glaucoma	5.23e-05	0.000673	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—PTGS2—glaucoma	4.98e-05	0.000641	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.85e-05	0.000624	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—MTHFR—glaucoma	4.83e-05	0.000622	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—ABCA1—glaucoma	4.79e-05	0.000617	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—CYP1B1—glaucoma	4.79e-05	0.000617	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—GSTT1—glaucoma	4.78e-05	0.000614	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—APOE—glaucoma	4.5e-05	0.000579	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—CAV1—glaucoma	4.46e-05	0.000574	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—GSTM1—glaucoma	3.83e-05	0.000493	CbGpPWpGaD
Balsalazide—PTGS2—Disease—CDKN2B—glaucoma	3.83e-05	0.000493	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—CYP1B1—glaucoma	3.81e-05	0.000489	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—ABCA1—glaucoma	3.81e-05	0.000489	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—MTHFR—glaucoma	3.39e-05	0.000436	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—NOS3—glaucoma	3.37e-05	0.000434	CbGpPWpGaD
Balsalazide—PTGS2—Disease—MTHFR—glaucoma	3.21e-05	0.000413	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—APOE—glaucoma	3.15e-05	0.000406	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—CAV1—glaucoma	3.12e-05	0.000402	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—PTGS2—glaucoma	3.08e-05	0.000397	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—GSTM1—glaucoma	3.04e-05	0.000391	CbGpPWpGaD
Balsalazide—PTGS2—Disease—APOE—glaucoma	2.99e-05	0.000384	CbGpPWpGaD
Balsalazide—PTGS2—Disease—CAV1—glaucoma	2.96e-05	0.000381	CbGpPWpGaD
Balsalazide—PTGS2—Disease—BAD—glaucoma	2.78e-05	0.000358	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—MTHFR—glaucoma	2.69e-05	0.000346	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—APOE—glaucoma	2.5e-05	0.000322	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—CAV1—glaucoma	2.48e-05	0.000319	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—NOS3—glaucoma	2.36e-05	0.000304	CbGpPWpGaD
Balsalazide—PTGS2—Disease—NOS3—glaucoma	2.24e-05	0.000288	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—PTGS2—glaucoma	2.16e-05	0.000278	CbGpPWpGaD
Balsalazide—PTGS2—Disease—CDKN1B—glaucoma	1.94e-05	0.000249	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—NOS3—glaucoma	1.88e-05	0.000241	CbGpPWpGaD
